Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the ...

This approach contributed to strong growth in Cologuard test utilization ... The Company matches a portion of Exact Sciences employees’ contributions annually in the form of the Company ...

The Company matches a portion of Exact Sciences employees’ contributions annually in the form of the Company’s common stock. (4) Represents impairment charges on the Company’s long-lived assets.

The Company matches a portion of Exact Sciences employees’ contributions annually in the form of the Company’s common stock. (3) Represents acquisition and related integration costs incurred ...

NOTE: Exact Sciences, Cologuard and Cologuard Plus are trademarks ... Risk Factors sections of our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, and ...

For more information about the Cologuard test, visit Cologuard.com. Rx only. About Exact Sciences Corp. This news ... of our most recent Annual Report on Form 10-K and any subsequent Quarterly ...

NOTE: Exact Sciences, Cologuard and Cologuard Plus are trademarks or registered ... are described in the Risk Factors sections of our most recent Annual Report on Form 10-K and any subsequent ...

About Exact Sciences Corp. NOTE: Exact Sciences, Cologuard and Cologuard Plus are ... Factors sections of our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form ...

Exact Sciences Corporation is a leading provider of non-invasive cancer screening and therapy selection tests with stool-based test Cologuard ... Electrical products form the critical ...